Trials / Sponsors / Meissa Vaccines, Inc.
Meissa Vaccines, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6- Respiratory Syncytial Virus (RSV) | Phase 1 | 2021-06-03 |
| Unknown | Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) Covid19 | Phase 1 | 2021-04-12 |
| Completed | Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine RSV Infection | Phase 2 | 2020-12-29 |
| Completed | Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositiv Respiratory Syncytial Virus Infections | Phase 1 | 2020-06-09 |
| Completed | Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults Respiratory Syncytial Virus Infections | Phase 1 | 2020-01-14 |